Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging

Bioconjugate Chemistry

Volumn 24, Issue 9, 2013, Pages 1455-1467

  Andreozzi, Erica ^a,e   Wang, Peter ^a   Valenzuela, Anthony ^d   Tu, Chuqiao ^a   Gorin, Fredric ^d   Dhenain, Marc ^b,c   Louie, Angelique ^a  

^a University of California Davis   (United States)

^b CNRS   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; LIPOSOMES; NANOMAGNETICS; NANOPARTICLES; POSITRON EMISSION TOMOGRAPHY; SOLUTIONS; TARGETED DRUG DELIVERY;

CHEMICAL DEGRADATION; CONTROLLED RELEASE; GADOLINIA; GD-DOTA; LIPID CORES; LIPID NANOPARTICLES; MULTIMODAL IMAGING AGENTS; POLYMERIC NANOPARTICLES; RELAXIVITY; SYNTHESIS AND CHARACTERIZATIONS;

MAGNETIC RESONANCE IMAGING;

GADOTERIC ACID; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MOUSE; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; SYNTHESIS;

ANIMALS; CELL LINE; CELL SURVIVAL; CONTRAST MEDIA; HETEROCYCLIC COMPOUNDS; LIPIDS; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; ORGANOMETALLIC COMPOUNDS;

EID: 84884409674     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300605f     Document Type: Article

References (128)

1. Almeida, A. J. and Souto, E. (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins Adv. Drug Delivery Rev. 59, 478-490 (Pubitemid 47260710)
2. Mehnert, W. and Mäder, K. (2001) Solid lipid nanoparticles: Production, characterization and applications Adv. Drug Delivery Rev. 47, 165-196 (Pubitemid 32324113)
3. Blasi, P., Giovagnoli, S., Schoubben, A., Ricci, M., and Rossi, C. (2007) Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Delivery Rev. 59, 454-477 (Pubitemid 47259226)
4. Rawat, M., Singh, D., and Saraf, S. (2008) Lipid carriers: A versatile delivery vehicle for proteins and peptides J. Pharm. Soc. Jpn. 128, 269-280 (Pubitemid 351237899)
5. Muller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Zurmuhlen, A., Weyhers, H., Freitas, C., and Ruhl, D. (1995) Solid lipid nanoparticles (SLN)- An alternative colloidal carrier system for controlled drug-delivery Eur. J. Pharm. Biopharm. 41, 62-69
6. Martins, S., Sarmento, B., Ferreira, D. C., and Souto, E. B. (2007) Lipid-based colloidal carriers for peptide and protein delivery-liposomes versus lipid nanoparticles Int. J. Nanomed. 2, 595-607
7. zur Mühlen, A., Schwarz, C., and Mehnert, W. (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism Eur. J. Pharm. Biopharm. 45, 149-155 (Pubitemid 28167741)
8. Muller, R. H., Mader, K., and Gohla, S. (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art Eur. J. Pharm. Biopharm. 50, 161-177 (Pubitemid 30326695)
9. Baratchi, S., Kanwar, R. K., Khoshmanesh, K., Vasu, P., Ashok, C., Hittu, M., Parratt, A., Krishnakumar, S., Sun, X. Y., Sahoo, S. K., and Kanwar, J. R. (2009) Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases Curr. Nanosci. 5, 15-25
10. Rai, S., Paliwal, R., Gupta, P. N., Khatri, K., Goyal, A. K., Vaidya, B., and Vyas, S. P. (2008) Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: One step up in nanotechnology Curr. Nanosci. 4, 30-44 (Pubitemid 351513459)
11. Uner, M. (2006) Preparation, characterization and physico-chemical properties of Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC): Their benefits as colloidal drug carrier systems Pharmazie 61, 375-386 (Pubitemid 43724410)
12. Wang, S. P., Chen, T. K., Chen, R. E., Hu, Y. Y., Chen, M. W., and Wang, Y. T. (2012) Emodin loaded solid lipid nanoparticles: Preparation, characterization and antitumor activity studies Int. J. Pharm. 430, 238-246
13. Olbrich, C., Kayser, O., and Muller, R. H. (2002) Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity Int. J. Pharm. 237, 119-128 (Pubitemid 34310485)
14. Celia, C., Cosco, D., Paolino, D., and Fresta, M. (2011) Nanoparticulate devices for brain drug delivery Med. Res. Rev. 31, 716-756
15. Kaur, I. P., Bhandari, R., Bhandari, S., and Kakkar, V. (2008) Potential of solid lipid nanoparticles in brain targeting J. Controlled Release 127, 97-109
16. Gupta, Y., Jain, A., and Jain, S. K. (2007) Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain J. Pharm. Pharmacol. 59, 935-940 (Pubitemid 47051073)
17. Jain, S. K., Chaurasiya, A., Gupta, Y., Jain, A., Dagur, P., Joshi, B., and Katoch, V. M. (2008) Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting J. Microencapsulation 25, 289-297 (Pubitemid 352025005)
18. Reddy, L., Sharma, R., Chuttani, K., Mishra, A., and Murthy, R. (2005) Influence of administration route on tumro uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's Lymphoma tumor bearing mice J. Controlled Release 105, 185-198 (Pubitemid 40941985)
19. Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., and Alsarra, I. A. (2010) Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer Int. J. Med. Sci. 7, 398-408
20. Lu, B., Xiong, S. B., Yang, H., Yin, X. D., and Chao, R. B. (2006) Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases Eur. J. Pharm. Sci. 28, 86-95
21. Seyfoddin, A., Shaw, J., and Al-Kassas, R. (2010) Solid lipid nanoparticles for ocular drug delivery Drug Delivery 17, 467-489
22. Li, R., Jiang, S. M., Liu, D. F., Bi, X. Y., Wang, F. Z., Zhang, Q., and Xu, Q. W. (2011) A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide J. Microencapsulation 28, 134-141
23. Kalam, M. A., Sultana, Y., Ali, A., Aqil, M., Mishra, A. K., and Chuttani, K. (2010) Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system J. Drug Target 18, 191-204
24. Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Guneri, T., and Caramella, C. (2008) Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364, 76-86
25. Jaafar-Maalej, C., Andrieu, V., Elaissari, A., and Fessi, H. (2011) Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release J. Nanosci. Nanotechnol. 11, 1841-1851
26. Sanna, V., Kirschvink, N., Gustin, P., Gavini, E., Roland, I., Delattre, L., and Evrard, B. (2004) Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 5.
27. Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., Braun, A., and Muller-Goymann, C. (2010) A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung Eur. J. Pharm. Biopharm. 75, 107-116
28. Souto, E. B., Wissing, S. A., Barbosa, C. M., and Muller, R. H. (2004) Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery Int. J. Pharm. 278, 71-77 (Pubitemid 38670438)
29. Jain, S. K., Chourasia, M. K., Masuriha, R., Soni, V., Jain, A., Jain, N. K., and Gupta, Y. (2005) Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery Drug Delivery 12, 207-215 (Pubitemid 40981283)
30. Mandawgade, S. D. and Patravale, V. B. (2008) Development of SLNs from natural lipids: Application to topical delivery of tretinoin Int. J. Pharm. 363, 132-138
31. Maia, C. S., Mehnert, W., and Schafer-Korting, M. (2000) Solid lipid nanoparticles as drug carriers for topical glucocorticoids Int. J. Pharm. 196, 165-167 (Pubitemid 30105735)
32. Uner, M. and Yener, G. (2007) Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives Int. J. Nanomed. 2, 289-300 (Pubitemid 350047774)
33. Wissing, S. A. and Muller, R. H. (2002) Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration J. Controlled Release 81, 225-233 (Pubitemid 34607144)
34. Maia, C. S., Mehnert, W., Schaller, M., Korting, H. C., Gysler, A., Haberland, A., and Schafer-Korting, M. (2002) Drug targeting by solid lipid nanoparticles for dermal use J. Drug Targeting 10, 489-495 (Pubitemid 35230199)
35. Vighi, E. and Leo, E. (2012) Studying the in vitro behavior of cationic solid lipid nanoparticles as a nonviral vector Nanomedicine 7, 9-12
36. Vighi, E., Montanari, M., Ruozi, B., Iannuccelli, V., and Leo, E. (2012) The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier Drug Delivery 19, 1-10
37. Jin, J., Bae, K. H., Yang, H., Lee, S. J., Kim, H., Kim, Y., Joo, K. M., Seo, S. W., Park, T. G., and Nam, D. H. (2011) In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles Bioconjugate Chem. 22, 2568-2572
38. Wen, C. J., Yen, T. C., Al-Suwayeh, S. A., Chang, H. W., and Fang, J. Y. (2011) In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios Nanomedicine 6, 1545-1559
39. Ye, J. S., Wang, A. H., Liu, C. X., Chen, Z. J., and Zhang, N. (2008) Anionic solid lipid nanoparticles supported on protamine/DNA complexes Nanotechnology 19, 285708-285717
40. Kuo, Y. C. and Wang, C. C. (2010) Electrophoresis of human brain microvascular endothelial cells with uptake of cationic solid lipid nanoparticles: Effect of surfactant composition Colloids Surf., B: Biointerfaces 76, 286-291
41. Vighi, E., Montanari, M., Ruozi, B., Tosi, G., Magli, A., and Leo, E. (2010) Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter Eur. J. Pharm. Biopharm. 76, 384-393
42. Agarwal, A., Majumder, S., Agrawal, H., Majumdar, S., and Agrawal, G. P. (2011) Cationized albumin conjugated solid lipid nanoparticles as vectors for brain delivery of an anti-cancer drug Curr. Nanosci. 7, 71-80
43. Doroud, D., Vatanara, A., Zahedifard, F., Gholami, E., Vahabpour, R., Najafabadi, A. R., and Rafati, S. (2010) Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations J. Pharm. Pharm. Sci. 13, 320-335
44. Taveira, S. F., Araujo, L., de Santana, D., Nomizo, A., de Freitas, L. A. P., and Lopez, R. F. V. (2012) Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin J. Biomed. Nanotechnol. 8, 219-228
45. Choi, S. H., Jin, S. E., Lee, M. K., Lim, S. J., Park, J. S., Kim, B. G., Ahn, W. S., and Kim, C. K. (2008) Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells Eur. J. Pharm. Biopharm 68, 545-554 (Pubitemid 351318200)
46. Goppert, T. M. and Muller, R. H. (2005) Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns J. Drug Target 13, 179-187 (Pubitemid 40668171)
47. Sanjula, B., Shah, F. M., Javed, A., and Alka, A. (2009) Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement J. Drug Target 17, 249-256
48. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., and Alyautdin, R. (2002) Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier J. Drug Target 10, 317-325 (Pubitemid 34746313)
49. Koffie, R. M., Farrar, C. T., Saidi, L. J., William, C. M., Hyman, B. T., and Spires-Jones, T. L. (2011) Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging Proc. Natl. Acad. Sci. U. S. A. 108, 18837-18842
50. Tian, X. H., Lin, X. N., Wei, F., Feng, W., Huang, Z. C., Wang, P., Ren, L., and Diao, Y. (2011) Enhanced brain targeting of Temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles Int. J. Nanomed. 6, 445-452
51. Sarmento, B., Mazzaglia, D., Bonferoni, M. C., Neto, A. P., Monteiro, M. D., and Seabra, V. (2011) Effect of chitosan coating in overcoming the phagocytosis of insulin loaded solid lipid nanoparticles by mononuclear phagocyte system Carbohydr. Polym. 84, 919-925
52. Malhotra, M. and Prakash, S. (2011) Targeted drug delivery across blood-brain-barrier using cell penetrating peptides tagged nanoparticles Curr. Nanosci. 7, 81-93
53. Stevens, P. J., Sekido, M., and Lee, R. J. (2004) Synthesis and evaluation of a hematoporphyrin derivative in a folate receptor-targeted solid-lipid nanoparticle formulation Anticancer Res. 24, 161-165 (Pubitemid 38279703)
54. Andreozzi, E., Seo, J. W., Ferrara, K., and Louie, A. (2011) Novel method to label solid lipid nanoparticles with (64)Cu for positron emission tomography imaging Bioconjugate Chem. 22, 808-818
55. Videira, M. A., Gano, L., Santos, C., Neves, M., and Almeida, A. J. (2006) Lymphatic uptake of lipid nanoparticles following endotracheal administration J. Microencapsulation 23, 855-862 (Pubitemid 46332097)
56. Liu, W., Liang, J. G., Zhu, Y. L., Xu, H. B., He, Z. K., and Yang, X. L. (2006) CdSe/ZnS quantum dots loaded solid lipid nanoparticles: Novel luminescent nanocomposite particles, in Eco-Materials Processing & Design Vii (Kim, H. S., Li, Y. B., and Lee, S. W., Eds.) pp 170-173, Trans Tech Publications Ltd, Zurich-Uetikon. (Pubitemid 350048911)
57. Reimold, I., Domke, D., Bender, B., Seyfried, C., Radunz, H., and Fricker, G. (2008) Delivery of nanoparticles to the brain detected by fluorescence microscopy Eur. J. Pharm. Biopharm. 70, 627-632
58. Liu, W., He, Z. K., Liang, J. G., Zhu, Y. L., Xu, H. B., and Yang, X. L. (2008) Preparation and characterization of novel fluorescent nanocomposite particles: CdSe/ZnS core-shell quantum dots loaded solid lipid nanoparticles J. Biomed. Mater. Res., Part A 84A, 1018-1025 (Pubitemid 351295012)
59. Chen, D. B., Yang, T. Z., Lu, W. L., and Zhang, Q. (2001) In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel Chem. Pharm. Bull. 49, 1444-1447 (Pubitemid 33043274)
60. Esposito, E., Fantin, M., Marti, M., Drechsler, M., Paccamiccio, L., Mariani, P., Sivieri, E., Lain, F., Menegatti, E., Morari, M., and Cortesi, R. (2008) Solid lipid nanoparticles as delivery systems for bromocriptine Pharm. Res. 25, 1521-1530
61. Fundaro, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., and Gasco, M. R. (2000) Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: Pharmacokinetics and tissue distribution after i.v. administration to rats Pharmacol. Res. 42, 337-343
62. Bui, T., Stevenson, J., Hoekman, J., Zhang, S. R., Maravilla, K., and Ho, R. J. Y. (2010) Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging Plos One 5, e13082
63. Peira, E., Marzola, P., Podio, V., Aime, S., Sbarbati, A., and Gasco, M. R. (2003) In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide J. Drug Target 11, 19-24 (Pubitemid 36527392)
64. Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Griffioen, A. W., and Nicolay, K. (2006) Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging NMR Biomed. 19, 142-164 (Pubitemid 43250800)
65. Beduneau, A., Hindre, F., Clavreul, A., Leroux, J. C., Saulnier, P., and Benoit, J. P. (2008) Brain targeting using novel lipid nanovectors J. Controlled Release 126, 44-49 (Pubitemid 351175685)
66. Sun, J. H., Zheng, W. L., Zhang, H., Wu, T., Yuan, H., Yang, X. M., and Zhang, S. Z. (2011) Development of nanoparticle-based magnetic resonance colonography Magn. Reson. Med. 65, 673-679
67. Hu, F. Q., Hong, Y., and Yuan, H. (2004) Preparation and characterization of solid lipid nanoparticles containing peptide Int. J. Pharm. 273, 29-35 (Pubitemid 38317037)
68. Zhang, Z. H., Lv, H. X., and Zhou, J. P. (2009) Novel solid lipid nanoparticles as carriers for oral administration of insulin Pharmazie 64, 574-578
69. Jiao, J. and Burgess, D. J. (2003) Rheology and stability of water-in-oil-in-water multiple emulsions containing Span 83 and Tween 80 AAPS PharmSci 5, 62-73
70. Ugazio, E., Cavalli, R., and Gasco, M. R. (2002) Incorporation of cyclosporin A in solid lipid nanoparticles (SLN) Int. J. Pharm. 241, 341-344 (Pubitemid 34718035)
71. Li, Z., Li, X. W., Zheng, L. Q., Lin, X. H., Geng, F., and Yu, L. (2010) Bovine serum albumin loaded solid lipid nanoparticles prepared by double emulsion method Chem. Res. Chin. Univ. 26, 136-141
72. Xie, S. Y., Wang, S. L., Zhao, B. K., Han, C., Wang, M., and Zhou, W. Z. (2008) Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles Colloids Surf., B: Biointerfaces 67, 199-204
73. Gallarate, M., Trotta, M., Battaglia, L., and Chirio, D. (2009) Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation J. Microencapsulation 26, 394-402
74. Ce, Q., Yan, C., Qing-Zhe, J., and Xing-Guo, W. (2011) Preparation and characterization of catalase-loaded solid lipid nanoparticles protecting enzyme against proteolysis J. Mol. Sci. 12, 4282-4293
75. Chambi, H. N. M., Alvim, I. D., Barrera-Arellano, D., and Grosso, C. R. F. (2008) Solid lipid microparticles containing water-soluble compounds of different molecular mass: Production, characterisation and release profiles Food Res. Int. 41, 229-236
76. Garcia-Fuentes, M., Torres, D., and Alonso, M. J. (2003) Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules Colloids Surf., B: Biointerfaces 27, 159-168 (Pubitemid 36042758)
77. Singh, S., Dobhal, A. K., Jain, A., Pandit, J. K., and Chakraborty, S. (2010) Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine Chem. Pharm. Bull. 58, 650-655
78. You, J., Wan, F., de Cui, F., Sun, Y., Du, Y.-Z., and Hu, F. Q. (2007) Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles Int. J. Pharm. 343, 270-276 (Pubitemid 47321031)
79. Liu, J., Gong, T., Wang, C. G., Zhong, Z. R., and Zhang, Z. R. (2007) Solid lipid nanoparticles loaded with insulin by sodium cholate- phosphatidylcholine-based mixed micelles: Preparation and characterization Int. J. Pharm. 340, 153-162 (Pubitemid 47044961)
80. O'Brien, J., Wilson, I., Orton, T., and Pognan, F. (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity Eur. J. Biochem. 267, 5421-5426
81. Paxinos, G. and Franklin, K. (2001) The Mouse Brain in Stereotaxic Coordinates, 2 nd ed., pp 107-120, Academic Press, San Diego.
82. Mukherjee, S., Ray, S., and Thakur, R. S. (2009) Solid lipid nanoparticles: a modern formulation approach in drug delivery system Indian Journal of Pharmaceutical Sciences 71, 349-358
83. Saha, R. N., Vasanthakumar, S., Bende, G., and Snehalatha, M. (2010) Nanoparticulate drug delivery systems for cancer chemotherapy Mol. Membr. Biol. 27, 215-231
84. Moghimi, S. M., Hunter, A. C., and Murray, J. C. (2001) Long-circulating and target-specific nanoparticles: Theory to practice Pharmacol. Rev. 53, 283-318 (Pubitemid 32476118)
85. Barbu, E., Molnar, E., Tsibouklis, J., and Gorecki, D. C. (2009) The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier Expert Opin. Drug Delivery 6, 553-565
86. Mohapatra, M. and Mishra, A. K. (2011) Effect of submicellar concentrations of conjugated and unconjugated bile salts on the lipid bilayer membrane Langmuir 27, 13461-13467
87. Albalak, A., Zeidel, M. L., Zucker, S. D., Jackson, A. A., and Donovan, J. M. (1996) Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes Biochemistry 35, 7936-7945 (Pubitemid 26202534)
88. Rotunda, A. M., Suzuki, H., Moy, R. L., and Kolodney, M. S. (2004) Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution Dermatol. Surg. 30, 1001-1008 (Pubitemid 38890909)
89. Cardenas, M., Schillen, K., Alfredsson, V., Duan, R. D., Nyberg, L., and Amebrant, T. (2008) Solubilization of sphingornyelin vesicles by addition of a bile salt Chem. Phys. Lipids 151, 10-17 (Pubitemid 350161885)
90. Suzuki, K., Hasegawa, T., Takamura, Y., Takahashi, K., Asano, H., and Ueno, M. (1996) Behaviors of sodium taurocholate and sodium taurodeoxycholate in binary mixed micelles of bile salt and nonionic surfactant Langmuir 12, 5536-5540 (Pubitemid 126599489)
91. Sjostrom, B., Kaplun, A., Talmon, Y., and Cabane, B. (1995) Structures of nanoparticles prepared from oil-in-water emulsions Pharm. Res. 12, 39-48
92. Triplett, M. D. and Rathman, J. F. (2009) Optimization of beta-carotene loaded solid lipid nanoparticles preparation using a high shear homogenization technique J. Nanopart. Res. 11, 601-614
93. Siekmann, B. and Westesen, K. (1996) Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions Eur. J. Pharm. Biopharm. 42, 104-109 (Pubitemid 26173945)
94. Rupp, C., Steckel, H., and Muller, B. W. (2010) Mixed micelle formation with phosphatidylcholines: The influence of surfactants with different molecule structures Int. J. Pharm. 387, 120-128
95. You, J., Wan, F., de Cui, F., Sun, Y., Du, Y. Z., and Hu, F. Q. (2007) Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles Int. J. Pharm. 343, 270-276 (Pubitemid 47321031)
96. Kovacevic, A., Savic, S., Vuleta, G., Muller, R. H., and Keck, C. M. (2011) Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure Int. J. Pharm. 406, 163-172
97. Prombutara, P., Kulwatthanasal, Y., Supaka, N., Sramala, I., and Chareonpornwattana, S. (2012) Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity Food Control 24, 184-190
98. Accardo, A., Tesauro, D., Aloj, L., Pedone, C., and Morelli, G. (2009) Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI Coord. Chem. Rev. 253, 2193-2213
99. Villaraza, A. J. L., Bumb, A., and Brechbiel, M. W. (2010) Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics Chem. Rev. 110, 2921-2959
100. Yuan, H., Jiang, S. P., Du, Y. Z., Miao, J., Zhang, X. G., and Hu, F. Q. (2009) Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles Colloids Surf., B: Biointerfaces 70, 248-253
101. Villa, C. H., Lawson, L. B., Li, Y. M., and Papadopoulos, K. D. (2003) Internal coalescence as a mechanism of instability in water-in-oil-in-water double-emulsion globules Langmuir 19, 244-249
102. Caravan, P., Ellison, J. J., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications Chem. Rev. 99, 2293-2352 (Pubitemid 30498114)
103. Tu, C. Q., Osborne, E. A., and Louie, A. Y. (2011) Activatable T (1) and T (2) magnetic resonance imaging contrast agents Ann. Biomed. Eng. 39, 1335-1348
104. Olbrich, C. and Muller, R. H. (1999) Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures Int. J. Pharm. 180, 31-39 (Pubitemid 29131440)
105. Silva, A. C., Gonzalez-Mira, E., Garcia, M. L., Egea, M. A., Fonseca, J., Silva, R., Santos, D., Souto, E. B., and Ferreira, D. (2011) Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound Colloids Surf., B: Biointerfaces 86, 158-165
106. Scholer, N., Zimmermann, E., Katzfey, U., Hahn, H., Muller, R. H., and Liesenfeld, O. (2000) Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages Int. J. Pharm. 196, 235-239 (Pubitemid 30105751)
107. Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-da-Silva, A., Souto, E. B., and Ferreira, D. C. (2012) Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway Int. J. Pharm. 430, 216-227
108. Weyhers, H., Ehlers, S., Hahn, H., Sout, E. B., and Muller, R. H. (2006) Solid lipid nanoparticles (SLN)-Effects of lipid composition on in vitro degradation and in vivo toxicity Pharmazie 61, 539-544 (Pubitemid 43989132)
109. Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H., and Liesenfeld, O. (2001) Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages Int. J. Pharm. 221, 57-67 (Pubitemid 32524035)
110. Olbrich, C., Scholer, N., Tabatt, K., Kayser, O., and Muller, R. H. (2004) Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production J. Pharm. Pharmacol. 56, 883-891 (Pubitemid 38885982)
111. Müller, R. H., Maassen, S., Schwarz, C., and Mehnert, W. (1997) Solid lipid nanoparticles (SLN) as potential carrier for human use: interaction with human granulocytes J. Controlled Release 47, 261-269 (Pubitemid 27220209)
112. Cavalli, R., Bocca, C., Miglietta, A., Caputo, O., and Gasco, M. R. (1999) Albumin adsorption on stealth and non-stealth solid lipid nanoparticles STP Pharma Sci. 9, 183-189 (Pubitemid 29284019)
113. Bocca, C., Caputo, O., Cavalli, R. B., Gabriel, L., Miglietta, A., and Gasco, M. R. (1998) Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles Int. J. Pharm. 175, 185-193 (Pubitemid 28517974)
114. Illum, L., Davis, S. S., Muller, R. H., Mak, E., and West, P. (1987) The organ biodistribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer- poloxamine 908 Life Sci. 40, 367-374
115. Muller, R. H., Maassen, S., Weyhers, H., and Mehnert, W. (1996) Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407 J. Drug Target 4, 161-170 (Pubitemid 26390298)
116. Muller, R. H., Maassen, S., Weyhers, H., Specht, F., and Lucks, J. S. (1996) Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles Int. J. Pharm. 138, 85-94 (Pubitemid 26241925)
117. Mehnert, W. and Mader, K. (2012) Solid lipid nanoparticles Production, characterization and applications Adv. Drug Delivery Rev. 64, 83-101
118. Liu, H., Gong, T., Fu, H. L., Wang, C. G., Wang, X. L., Chen, Q., Zhang, Q., He, Q., and Zhang, Z. R. (2008) Solid lipid nanoparticles for pulmonary delivery of insulin Int. J. Pharm. 356, 333-344
119. Zhou, H. F., Ma, Q. H., Xia, Q., Lu, Y. Y., Gu, N., Miao, X., and Luo, D. (2007) Preparation and cytotoxicity of imiquimod-loaded solid lipid nanoparticles, in Nanoscience and Technology, Pts 1 and 2 (Bai, C., Xie, S., and Zhu, X., Eds.) pp 271-274, Trans Tech Publications Ltd, Stafa-Zurich. (Pubitemid 351151024)
120. Joshi, M. D. and Müller, R. H. (2009) Lipid nanoparticles for parenteral delivery of actives Eur. J. Pharm. Biopharm. 71, 161-172
121. Nassimi, M., Schleh, C., Lauenstein, H.-D., Hussein, R., Lubbers, K., Pohlmann, G., Switalla, S., Sewald, K., Muller, M., Krug, N., Muller-Goymann, C. C., and Braun, A. (2009) Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models Inhalation Toxicol. 21 (Suppl 1) 104-9
122. Petiet, A. and Dhenain, M. (2011) Improvement of microscopic MR imaging of amyloid plaques with targeting and non-targeting contrast agents Curr. Med. Imaging Rev. 7, 8-15
123. Blower, P. J., Lewis, J. S., and Zweit, J. (1996) Copper radionuclides and radiopharmaceuticals in nuclear medicine Nucl. Med. Biol. 23, 957-980 (Pubitemid 27050682)
124. Mulder, W. J. M., Strijkers, G. J., Van Tilborg, G. A. F., Cormode, D. P., Fayad, Z. A., and Nicolay, K. (2009) Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging Acc. Chem. Res. 42, 904-914
125. Harms, M. and Muller-Goymann, C. C. (2011) Solid lipid nanoparticles for drug delivery J. Drug Delivery Sci. Technol. 21, 89-99
126. Morel, S., Ugazio, E., Cavalli, R., and Gasco, M. R. (1996) Thymopentin in solid lipid nanoparticles Int. J. Pharm. 132, 259-261 (Pubitemid 26158724)
127. Olbrich, C., Gessner, A., Schroder, W., Kayser, O., and Muller, R. H. (2004) Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption J. Controlled Release 96, 425-435 (Pubitemid 38553921)
128. Li, S. Y., Zhao, B. K., Wang, F. H., Wang, M., Xie, S. Y., Wang, S. L., Han, C., Zhu, L. Y., and Zhou, W. Z. (2010) Yak interferon-alpha loaded solid lipid nanoparticles for controlled release Res. Vet. Sci. 88, 148-153